%0 Case Reports
%T Acquired cutis laxa secondary to Sweet syndrome in a child (Marshall syndrome): A rare case report.
%A Jagati A
%A Shrivastava S
%A Baghela B
%A Agarwal P
%A Saikia S
%J J Cutan Pathol
%V 47
%N 2
%D Feb 2020
%M 31437319
%F 1.458
%R 10.1111/cup.13567
%X Sweet syndrome is rare in the pediatric population and usually responds well to treatment, resolving without sequelae. Marshall syndrome is a rare pediatric skin disease characterized by loss of elastic tissue (cutis laxa) secondary to acquired, localized neutrophilic dermatitis without any internal organ involvement. Only few cases of Marshall syndrome (acquired cutis laxa type II) have been reported. Systemic steroids and dapsone show excellent results in Sweet syndrome. Although there is no satisfactory treatment for cutis laxa, dapsone can be used in the acute phase for control of swelling.